Friberg Gregory R
- SEC CIK
- 0002038768
In the past year, 2 open-market sale filings worth $558.6K and no purchases.
Current role at each company
- BMRN Biomarin Pharmaceutical IncEVP, Chief R&D Officeras of May 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $558.6K
- 2 filings
- Net
- −$558.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Friberg Gregory R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing) | May 7 | 4 days | Friberg Gregory REVP, Chief R&D Officer | SSale | −3.28K | $53.85 | −$176.7K | −6.0%51.8K after | |
| Feb 26, 2026 (view filing) | Feb 26 | Same day | Friberg Gregory REVP, Chief R&D Officer | SSale | −6.33K | $60.38 | −$382.0K | −14.4%37.6K after |